Abstract
A comprehensive definition of a biomaterial was provided at the National Institutes of Health (NIH) Consensus Development Conference on the Clinical Applications of Biomaterials in the United States.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsGENERAL REFERENCES
Hench LL (1991) Bioceramics: from concept to clinic. J Am Ceram Soc 74(7):1487–1510 (1,844 cites by 2011)
Hench LL, Wilson JK (eds) (1993) An introduction to bioceramics. World Scientific, Singapore, A collection of chapters on different aspects of bioceramics written by expects in the field. This is an excellent but aging resource
LeGeros RZ, LeGeros JP (eds) (1998) In: Bioceramics, Volume 11, Proceedings of the 11th international symposium on ceramics in medicine. World Scientific, Singapore. The most recently published proceedings in this annual conference series. Covers the latest developments in all aspects of the field of bioceramics
Marieb EN (2008) Human anatomy and physiology, 8th edn. Benjamin Cummings, Menlo Park, Reference for a more detailed description of bone
Park JB, Lakes RS (2010) Biomaterials science and engineering. Reprint of 3 E (2007) Springer, New York. A textbook covering all aspects of biomaterials. The section covering ceramic implant materials is quite brief but there is information about polymers and metals and a general background about the field
Ravaglioli A, Krajewski A (1992) Bioceramics: materials, properties, and application. Chapman and Hall, London, Covers history of bioceramics, scientific background to the field, and state-of-the-art as of 1991
Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (2004) Biomaterials science, 2nd edn. Elsevier, Amsterdam, Used in our courses
Williams DF (1999) The Williams dictionary of biomaterials. Liverpool University Press, Liverpool, The latest collection of definitions used in the field of biomaterials
Yamamuro T, Hench LL, Wilson-Hench J (eds) (1990) Handbook of bioactive ceramics, vol I: bioactive glasses and glass ceramics, vol II: calcium phosphate and hydroxylapatite ceramics. CRC Press, Boca Raton, A collection of articles on bioactive and resorbable bioceramics
Journals and Conference Proceedings
The following journals and conference proceedings are the main places where reports of advances in bioceramics are reported
Acta Biomaterialia
Bioceramics. This is the title of the proceedings of the international symposium on ceramics in Medicine. The symposium has been held annually since 1988
Biomedical Materials and Engineering. Covers all aspects of biomaterials and includes details of clinical studies. Usually found in with medical journals rather than physical science or engineering publications
Journal of Materials Science Materials in Medicine. Spun off from Journal of Materials Science, this is another growing journal
Journal of the American Ceramic Society. Covers the entire ceramics field including bioceramics
Nature. A journal with a wide readership. Publishes important news articles having a significant impact on the field
SPECIFIC REFERENCES
Annual Book of ASTM Standards, 13.01, Medical Implants, ASTM, Philadelphia. The American Society for Testing and Materials (ASTM) has developed several standards related to bioceramics for surgical implants: the Annual Book of ASTM Standards
Bokros JC, LaGrange LD, Fadali AM, Vos KD, Ramos MD (1969) J Biomed Mater Res 3:497–528, First use of carbon heart valves in humans
Bonfield W, Grynpas MD, Tully AE, Bowman J, Abram J (1981) Hydroxyapatite reinforced polyethylene: a mechanically compatible implant. Biomaterials 2:185
Brömer H, Pfeil E, Käs HH (1973) German Patent 2,326,100. Patent for Ceravital
Chakrabarti O, Weisensel L, Sieber H (2005) Reactive melt infiltration processing of biomorphic Si–Mo–C ceramics from wood. J Am Ceram Soc 88(7):1792–1798
Cherukuri P, Glazer ES, Curley SA (2010) Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev 62:339, A recent review that covers not only oxides, but also other nanoparticles such as Au
Ducheyne P, Hench LL (1982) The processing and static mechanical properties of metal fibre reinforced bioglass®. J Mater Sci 17:595, Diffusion across a bioglass-metal interface
Galletti PM, Boretos JW (1983) Report on the consensus development conference on clinical applications of biomaterials. J Biomed Mater Res 17:539, Defined “biomaterial”
Hench LL (1991) Bioceramics: from concept to clinic. J Am Ceram Soc 74:1487, An excellent review on this topic
Hench LL, Andersson O (1993) Bioactive glasses. In: Hench LL, Wilson JK (eds) An introduction to bioceramics. World Scientific, Singapore, pp 41–62
Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldöfner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A (2005) Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia 21:673–647, A clinical trial on prostrate cancer patients
Klawitter JJ, Hulbert SF (1971) Application of porous ceramics for the attachment of load bearing orthopedic applications. J Biomed Mater Res 2:161, Determined that a minimum pore size of 100 μm is necessary for bone ingrowth
Lübbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, Huhn D (1996) Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res 56:4694, The ferrofluid contained 50–150nm diameter Fe3O4 particles and a 0.5T magnetic field was used
Mehmel M (1930) Z Kristallogr 75:323, One of two original determinations of the structure of hydroxyapatite. The structure was originally taken to be the same as that of fluorapatite, Ca10(PO4)6F2, which had been already resolved
Merwin GE, Wilson J, Hench LL (1984) In: Grote JJ (ed) Biomaterials in otology. Nijhoff, The Hague, pp 220–229, Description of bioglass
Náray-Szabó S (1930) The structure of apatite (CaF) Ca4(PO4)3. Z Kristallogr 75:387, The other early paper on the structure of hydroxyapatite
Posner AS, Perloff A, Diorio AF (1958) Refinement of the hydroxyapatite structure. Acta Crystallogr 11:308–309, Determined atom positions, bond lengths, and lattice parameters for the HA crystal structure
Roy DM, Linnehan SK (1974) Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange. Nature 247:220, Developed the natural-template method for making porous HA
Sarakiya M (1994) An introduction to biomimetics: a structural viewpoint. Microsc Res Techn 27:360, A very useful introduction
Sato T, Shimada M (1985) Transformation of yttria-doped tetragonal ZrO2 polycrystals by annealing in water. J Am Ceram Soc 68:356, Described the martensitic transformation in ZrO2 in aqueous environments
Wang Q, Huang W, Wang D, Darvell BW, Day DE, Rahaman MN (2006) Preparation of hollow hydroxyapatite microspheres. J Mater Sci Mater Med 17:641
Williams DF (ed) (1987) DiB: definitions in biomaterials. Elsevier, Amsterdam, pp 6–7, Includes a discussion of biocompatibility
WWW
Journal of Biomedical Materials Research: A and B. Now past volume 100. Find the Society for Biomaterials at http://www.biomaterials.org
www.mds.nordion.com/therasphere/. The TheraSphere® website
Author information
Authors and Affiliations
Corresponding author
1 People and History
Duchateau, Alexis (1714–1792) was the pharmacist in Paris who made the first porcelain dentures in ~1770.
Dubois de Chémant, Nicolas (1753–1824) wrote a dissertation on artificial teeth describing the advantages using mineral paste to make replacement teeth. He escaped to England from the French Revolution and later obtained porcelain paste from Wedgwood.
Gluck, Themistocles (1853–1942) is generally regarded as the inventor of artificial biomaterials (ivory was a favorite).
Hench, Larry (born 1938) developed Bioglass® in 1969. He is Emeritus Professor of Materials at Imperial College, London.
Hippocrates (460–370 BCE). One of his aphorisms can be translated as: those diseases which medicines do not cure, iron cures; those which iron cannot cure, fire cures; and those which fire cannot cure, are to be reckoned wholly incurable. Modern hyperthermia treatment uses ferrite nanoparticles to locally generate heat.
2 Exercises
-
35.1
Briefly compare and contrast the suitability of metals, ceramics, and polymers for use in biomedical applications. In your answer, consider the following factors: biocompatibility, mechanical properties, and ease of processing.
-
35.2
Alumina (Al2O3) ceramic implants are required to have a small grain size (<4.5 m). (a) Why do you think a small grain size is important? (b) How does the addition of MgO to the powder mixture help to keep the grain size small? (c) Are there any other ways that could be used to limit the extent of grain growth?
-
35.3
Explain why tetragonal zirconia polycrystal (TZP) and Mg-partially stabilized zirconia (PSZ) ceramics have higher toughness than alumina ceramics.
-
35.4
The Weibull modulus of an alumina bioceramic is given as 8.4. (a) What does a value of m = 8.4 imply? (b) For an implant made out of a metal, the value of m ~ 100. What implications would this have for lifetime predictions for the metal component compared to the alumina component? (c) How does the value of m affect the design of a component for a load-bearing application?
-
35.5
The composition of Bioglass® 45S5 is 45% SiO2, 24.5% Na2O, 24.4% CaO, and 6% P2O5. (a) Classify each of the oxide constituents of 45S5 as either network formers, modifiers, or intermediates. (b) What would the composition of Bioglass® 45S5 be in mol%? (c) Explain briefly how the structure of 45S5 differs from the silicate glasses described in Chapter 7 and what implications this difference has on the properties of 45S5.
-
35.6
The substitution of ions in the hydroxyapatite (HA) structure can change the lattice parameters of the unit cell. Explain how you think the substitution of Ca2+ for the following ions would change both the \( {a} \) and \( {c} \) lattice parameters: Sr2+, Ba2+, Pb2+, Mg2+, Mn2+, and Cd2+.
-
35.7
According to ASTM Standards [American Society for Testing and Materials (1990) Annual Book of ASTM Standards, Section 13, F 1185–1188], the acceptable composition for commercial HA is a minimum of 95% HA, as established by X-ray diffraction (XRD) analysis. Describe how XRD can be used to determine phase proportions in a mixture.
-
35.8
We mentioned that in steel fibers/bioactive glass composites it was important that there was chemical interaction between the two components to ensure stress transfer during loading. We have just formed a bioceramics company and want to hire you as a consultant. We want you to determine whether such interactions have occurred in a composite we have just made. What analytical technique or techniques would you use for your evaluation? Explain the reasoning behind your answer and some of the pros and cons of the technique or techniques you chose.
-
35.9
One of the advantages of plasma spraying for producing HA coatings on metallic implants is that the substrate temperature can be kept relatively low. What possible mechanisms can lead to a loss in the mechanical strength of a metal if it is exposed to high temperatures? (You can limit your discussion to the cases of Ti alloys and stainless steel).
-
35.10
Explain why the mechanical properties of turbostratic carbons such as LTI are different from those of graphite. Both are forms of carbon and are chemically identical.
-
35.11
We can use several definitions of a biomaterial. Discuss at least three that have been proposed and explain why you prefer the one given here.
-
35.12
Explain why HA and TCP behave differently in the body.
-
35.13
Name the two main types of bone. Say where they are found in the body and why.
-
35.14
Why is stress shielding a problem for prostheses?
-
35.15
Why is alumina used as the femoral ball, and why is so much work aimed at improving this device?
-
35.16
What is a bioactive ceramic, and why has Bioglass been so successful?
-
35.17
Discuss the composition and structure of Cerabone and explain why it was so designed.
-
35.18
Write down the general formula for HA and state its percentage in bone by weight and volume. How does its structure relate to its properties?
-
35.19
Discuss why thermal spraying is the preferred method for producing HA and TCP coatings.
-
35.20
Summarize and justify five uses for nanobioceramics.
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Carter, C.B., Norton, M.G. (2013). Ceramics in Biology and Medicine. In: Ceramic Materials. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3523-5_35
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3523-5_35
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3522-8
Online ISBN: 978-1-4614-3523-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)